Sibrotuzumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Sibrotuzumab Usage And Synthesis

Uses

Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC)[1].

References

[1] Scott AM, et al. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res. 2003 May;9(5):1639-47. PMID:12738716
[2] Kobayashi T, et al., Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts Using a Humanized Anti-Fibroblast Activation Protein Antibody. Mol Cancer Ther. 2024 Jul 2;23(7):1031-1042.

Sibrotuzumab(216669-97-5)Related Product Information

• Bapotulimab
• Telimomabaritox
• Zolimomabaritox
• OregovoMab
• Tesidolumab
• Relfovetmab
• Felvizumab
• Ontamalimab
• Icrucumab
• Immunoglobulin G1,anti-(human CD4 (antigen)) (human-mouse monoclonal cm-T412 g1-chain), disulfide withhuman-mouse monoclonal cm-T412 k-chain, dimer